Tibsovo approved for acute myeloid leukemia
Sunday, July 22, 2018 - 11:00
in Health & Medicine
Tibsovo tablets have been approved by the U.S. Food and Drug Administration to treat relapsed or refractory acute myeloid leukemia among people,